Company / PP&E per Share
Vir Biotechnology, Inc. PP&E per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.41
FY2025
5-year range
$0.34 / $0.81
FY2021-FY2025
Trend
-13.4%
vs FY2024
Sector context
#59 of 191
Health Care
What the data says
At $0.41, Vir Biotechnology, Inc.'s pp&e per share ranks #59 of 191 in the Health Care sector. PP&E per Share has declined for 3 consecutive years, from $0.81 in FY2022 to $0.41 in FY2025.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of +19.5%.
Declined from $0.72 to $0.41 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -20.4%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Sector benchmark
#59 of 191 in Health CareTop 31% of 191This company $0.41 Sector average $22.34
▼
-98.2% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 13.4% year-over-year.
- Ranks #59 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | -13.4% |
| FY2024 | $0.47 | -35.0% |
| FY2023 | $0.72 | -10.5% |
| FY2022 | $0.81 | +139.5% |
| FY2021 | $0.34 | +101.7% |
| FY2020 | $0.17 | -90.9% |
| FY2019 | $1.84 | +14.8% |
| FY2018 | $1.60 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026